Bristol Myers Squibb and bluebird bio get US FDA nod for Abecma (idecabtagene vicleucel) to treat relapsed or refractory multiple myeloma Read more
Hitachi Chemical Advanced Therapeutics Solutions, apceth Biopharma GmbH and bluebird bio to collaborate on strategic clinical and commercial manufacturing Read more